PSMA-PET/CT Could Redefine Staging in High-Risk Prostate Cancer Imaging plays a pivotal role in determining treatment for men with newly diagnosed, high-risk prostate cancer. A recent Danish study suggests that replacing the conventional F-18 sodium fluoride (NaF) PET/CT with F-18 PSMA-PET/CT could significantly alter metastatic staging and, in turn, treatment decisions. The findings, published in…